EQUITY RESEARCH Telecom, Media, Tech COMPANY UPDATE

Size: px
Start display at page:

Download "EQUITY RESEARCH Telecom, Media, Tech COMPANY UPDATE"

Transcription

1 A S D S N D F LIVEXLIVE ED IA O RD ( , 5.974, , , ) Relative Strength Index ( ) A x ember FINRA/SIPC Toll Free: EQUITY RESEARCH Telecom, edia, Tech COPANY UPDATE LiveXLive edia, Inc. (Nasdaq/LIVX) BUY 10K Shows Solid Progress $5.77 / Target:$7.00 LiveXLive edia is the first and only live music streaming and social media platform. On Friday, LiveX filed its FY K. There were no major surprises as the company continues to execute on its three-part plan: 1. Build a portfolio of music festivals to stream. It has 27 in the pipeline for the current fiscal year. 2. Attract viewers. In three festival ay lineup attracted 14 million viewers. It just streamed Rock in Rio Lisbon over the last two weekends and has the ontreux azz Festival Coming from une 29 to uly 14 It is targeting 100 million viewers this fiscal year. 3. onetize. As expected, signing new advertising/sponsorship/marketing deals should kick into high gear after the above two milestones are further along. FY2018 revenue was $7.2 mm, EBITDA was negative $12.5 mm and EPS was negative $0.48, all in line with expectations. Our Buy thesis was never predicated on FY2018 results, or FY2019 for that matter, but FY2019 should represent a reasonable representation of the business plan. Our updated model is included, with no material changes. uly 2, 2018 Barry. Sine Senior Research Analyst bsine@dawsonjames.com Estimates F2018A F2019E F2020E Revenue($000s) $7,195 $34,4 $147,040 1Q une 276 7,700 27,140 2Q September 372 9,000 37,280 3Q December 0 8,2 37,420 4Q arch 6,547 9,0 45,200 EPS ($0.48) ($0.39) $0.40 1Q arch (0.08) (0.12) (0.00) 2Q une (0.12) (0.12) Q September (0.10) (0.08) Q December (0.29) (0.07) 0.19 P/E (x) N/A N/A 14.5X EBITDA ($12,454) ($9,865) $29,816 EV/EBITDA (x) N/A N/A 9.4X Stock Data 52-Week Range $ $90.00 Shares Outstanding (mil.) 49.5 arket Capitalization (mil.) $285.9 Enterprise Value (mil.) $280.5 Debt to Capital 17.1% Book Value/Share $0.82 Price/Book 7.0 X Average Trading Volume (3-month) ill 0.1 Insider Ownership 57.8% Institutional Ownership 14.1% Short interest 0.6% We reiterate our Buy rating and $7 price target. When we initiated coverage, we noted that if the company appeared to be tracking towards our numbers, we would value the shares at a more peer-like $9. We note that peers now trade at an average of 10.2x, up from 8.9x putting fair value of LIVX to $10 on this basis. Price target and ratings changes over the past 3 years: Initiation - une 4, Buy - Price Target $7.00 Please find Important Disclosures beginning on Page 4. Page 1 of 5

2 LiveX Thesis Rolls On uly 2, 2018 On Friday, LiveX filed its 10K for the 2018 fiscal year. Of note was the fact that this included a full quarter of Slacker Radio, acquired at the end of December results. These were no surprises that jumped off the page at us, but we are focusing on future growth potential, and not past results. Given the relative inconsequential nature of the K, no earnings call is scheduled but that should change next quarter given how the une quarter is chock full of music festivals. The company webcast the Rock in Rio music festival from Lisbon over the last two weekends with this weekend featuring Katy Perry. We looked in on her live webcast and it was a pretty spectacular stage show. We expect that the company will provide viewership numbers of clusters of festivals, as it did in ay so perhaps we will see some data after the ontreux azz Festival ends on uly 14. We also note that the stock experienced some wild gyrations during the quarter as Russell added it to their microcap index on une 22. The stock hit a high of $11.11 on une 20, before closing Friday at $5.77. We now expect the stock to track more regularly toward our current target and for our target to increase as the company steadily hits its milestones. As we discussed in our initiation report, we value LIVX shares at $7 based on a multiple of 12x our FY2020 EBITDA multiple. With comps up about 10% since our initiation, we see greater potential upside if targets continue to be met. The key risks to our thesis are unchanged since our initiation, but with a bit more visibility on numbers now that a 10K including Slacker has been filed and with a successful Rock in Rio risks are a bit less. As we noted, we see LiveX s business plan in three parts. So the key risk would be in failure to execute. It has already gotten off to a good start with a solid stable of festivals, and appears to be starting to gain traction. It will be interesting to see if Slacker can post sequential growth in the une quarter after favorable management comments about subscriber numbers. On monetization, management cannot really attract much revenue until it can demonstrate viewership, so we do not expect much visibility on that front for the next quarter or two. So the key risks remain, with perhaps some minor mitigation in risk since our last report. LiveXLiveedia Page 2 of 5

3 uly 2, 2018 LiveXLive edia Income Forecast Dollars in thousands, except per share data E 2020E Fiscal years ended arch 31 1Q 2Q 3Q 4Q YEAR 1Q 2Q 3Q 4Q YEAR 1Q 2Q 3Q 4Q YEAR une Sept Dec arch une Sept Dec arch une Sept Dec arch Slacker Radio 6,795 6,795 7,000 7,000 7,000 7,000 28,000 7,140 7,280 7,420 7,700 29,540 YoY grow th 3.0% 312.1% 2% 4% 6% 10% 5.5% Seq grow th LiveXLive ,000 1,2 2,0 6,4 20,000 30,000 30,000 37,0 117,0 # of events Revenue per event $138 $41 $80 $100 $200 $2 $0 $239 $1,000 $1,0 $2,000 $2,0 $1,679 YoY grow th Seq grow th 185.7% -37.5% 100.0%.0% 0.0% 25.0% Revenue ,547 7,195 7,700 9,000 8,2 9,0 34,4 27,140 37,280 37,420 45, ,040 YoY grow th % % 45.1% 378.8% 252.5% 314.2% 353.6% 375.8% 326.8% Seq grow th 17.6% 116.9% 91.7% 1.2% 185.7% 137.4% 100.4% 120.8% Cost of Revenue ,543 6,694 3,0 5,000 2,0 2,0 13,0 10,000 10,000 7,0 7,0 35,000 Per festival , Gross argin ,200 4,000 5,7 7,000 20,9 17,140 27,280 29,920 37, ,040 As a percent of revenue 71.4% 80.7% 0.0% 7.0% 54.5% 44.4% 69.7% 73.7% 60.8% 63.2% 73.2% 80.0% 83.4% 76.2% Selling General and Admin 2,288 3,754 2,618 9,000,288 9,240 9,000 9,075 9,0 36,8 16,284 22,368 22,452 27,120 88,224 As a percent of revenue 828.1% % 137.5% 212.5% 120.0% 100.0% 110.0% 100.0% 106.9% 60.0% 60.0% 60.0% 60.0% 60.0% Related Party As a percent of revenue 24.2% 1.4% 1.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% Operating income (2,180) (3,543) (2,708) (9,087) (14,877) (5,040) (5,000) (3,325) (2,0) (,865) 856 4,912 7,468 10,580 23,816 Operating margin -65.5% -55.6% -40.3% -26.3% -46.1% 3.2% 13.2% 20.0% 23.4% 16.2% Interest expense (635) (759) (901) (1,628) (3,922) (900) (900) (900) (900) (3,600) (900) (900) (900) (900) (3,600) Fair value of w arrants (193) Earnings from investment in affiliate Impairment loss Loss on sale of investment in affiliate - (22) (22) (635) (759) (901) (1,457) (4,137) (900) (900) (900) (900) (3,600) (900) (900) (900) (900) (3,600) Pretax Income (2,8) (4,302) (3,608) (10,543) (19,014) (5,940) (5,900) (4,225) (3,400) (19,465) (44) 4,012 6,568 9,680 20,216 Taxes Net income - continuing ops (2,8) (4,302) (3,608) (10,549) (19,020) (5,940) (5,900) (4,225) (3,400) (19,465) (44) 4,012 6,568 9,680 20,216 Net income margin % -16.0% % % -77.1% -65.6% -51.2% -35.8% -56.5% -0.2% 10.8% 17.6% 21.4% 13.7% Diluted shares outstanding 35,528 36,016 36,543 36,568 39,595,0,525,5,575,538,600,625,6,675,638 Seq change , , EPS diluted ($0.08) ($0.12) ($0.10) ($0.29) ($0.48) ($0.12) ($0.12) ($0.08) ($0.07) ($0.39) ($0.00) $0.08 $0.13 $0.19 $0.40 EBITDA (1,562) (2,890) (1,339) (7,587) (12,454) (3,540) (3,0) (1,825) (1,000) (9,865) 2,356 6,412 8,968 12,080 29,816 Source: Company reports and Dawson ames estimates LiveXLiveedia Page 3 of 5

4 uly 2, 2018 Important Disclosures: LIVEXLIVE EDIA ORD ( , 5.974, , , ) 100 Relative Strength Index ( ) x A S D S N D F A Source: etastock Price target and ratings changes over the past 3 years: Initiated Buy une 4, 2018 Price Target $7.00 Dawson ames Securities, Inc. (the Firm ) is a member of the Financial Industry Regulatory Authority ( FINRA ) and the Securities Investor Protection Corporation ( SIPC ). The Firm does not make a market in the securities of the subject company (s). The Firm has NOT engaged in investment banking relationships with LIVX in the prior twelve months, as a manager or co-manager of a public offering and has NOT received compensation resulting from those relationships. The Firm may seek compensation for investment banking services in the future from the subject company(s). The Firm has NOT received other compensation from the subject company(s) in the last 12 months for services unrelated to the managing or co-managing of a public offering. Neither the research analyst(s) whose name appears on this report nor any member of his (their) household is an officer, director or advisory board member of these companies. The Firm and/or its directors and employees may own securities of the company(s) in this report and may increase or decrease holdings in the future. As of uly 2, 2018, the Firm as a whole did not beneficially own 1% or more of any class of common equity securities of the subject company (s) of this report. The Firm, its officers, directors, analysts or employees may effect transactions in and have long or short positions in the securities (or options or warrants related to those securities) of the company(s) subject to this report. The Firm may effect transactions as principal or agent in those securities. Analysts receive no direct compensation in connection with the Firm's investment banking business. All Firm employees, including the analyst(s) responsible for preparing this report, may be eligible to receive non-product or service specific monetary bonus compensation that is based upon various factors, including total revenues of the Firm and its affiliates as well as a portion of the proceeds from a broad pool of investment vehicles consisting of components of the compensation generated by investment banking activities, including but not limited to shares of stock and/or warrants, which may or may not include the securities referenced in this report. Although the statements in this report have been obtained from and are based upon recognized statistical services, issuer reports or communications, or other sources that the Firm believes to be reliable, we cannot guarantee their accuracy. All LiveXLiveedia Page 4 of 5

5 uly 2, 2018 opinions and estimates included in this report constitute the analyst s judgment as of the date of this report and are subject to change without notice. Information about valuation methods and risks can be found in the VALUATION and RISK FACTORS sections of this report. The securities of the company discussed in this report may be unsuitable for investors depending on their specific investment objectives and financial position. This report is offered for informational purposes only, and does not constitute an offer or solicitation to buy or sell any securities discussed herein in any jurisdiction where such would be prohibited. Additional information is available upon request. Ratings Definitions: 1) Buy: the analyst believes the price of the stock will appreciate and produce a total return of at least 20% over the next months; 2) Neutral: the analyst believes the price of the stock is fairly valued for the next months; 3) Sell: the analyst believes the price of the stock will decline by at least 20% over the next months and should be sold. The following chart reflects the range of current research report ratings for all companies followed by the analysts of the Firm. The chart also reflects the research report ratings relating to those companies for which the Firm has performed investment banking services in the last twelve months. Company Coverage Company Coverage Ratings Distribution # of Companies % of Total # of Comp % of Total arket Outperform (Buy) 21 88% 7 100% arket Perform (Neutral) 3 13% 0 0% arket Underperform (Sell) 0 0% 0 0% Total % 7 100% Analyst Certification: The analyst(s) whose name appears on this research report certifies that 1) all of the views expressed in this report accurately reflect his (their) personal views about any and all of the subject securities or issuers discussed; and 2) no part of the research analyst s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed by the research analyst in this research report; and 3) all Dawson ames employees, including the analyst(s) responsible for preparing this research report, may be eligible to receive non-product or service specific monetary bonus compensation that is based upon various factors, including total revenues of Dawson ames and its affiliates as well as a portion of the proceeds from a broad pool of investment vehicles consisting of components of the compensation generated by investment banking activities, including but not limited to shares of stock and/or warrants, which may or may not include the securities referenced in this report. LiveXLiveedia Page 5 of 5

INSTITUTIONAL RESEARCH Technology COMPANY UPDATE Member FINRA/SIPC

INSTITUTIONAL RESEARCH Technology COMPANY UPDATE Member FINRA/SIPC INSTITUTIONAL RESEARCH Technology COMPANY UPDATE Member FINRA/SIPC Toll Free: 561-391-5555 www.dawsonjames.com 1 North Federal Highway - Suite 500 Boca Raton, FL 33432 Pareteum (NYSE American/TEUM) BUY

More information

INSTITUTIONAL RESEARCH Biotechnology COMPANY UPDATE Member FINRA/SIPC

INSTITUTIONAL RESEARCH Biotechnology COMPANY UPDATE Member FINRA/SIPC INSTITUTIONAL RESEARCH Biotechnology COMPANY UPDATE Member FINRA/SIPC Toll Free: 561-391-5555 www.dawsonjames.com 1 North Federal Highway - Suite 500 Boca Raton, FL 33432 Acasti Pharma (Nasdaq/ACST) BUY

More information

INSTITUTIONAL RESEARCH Specialty Pharma COMPANY UPATE Member FINRA/SIPC

INSTITUTIONAL RESEARCH Specialty Pharma COMPANY UPATE Member FINRA/SIPC INSTITUTIONAL RESEARCH Specialty Pharma COMPANY UPATE Member FINRA/SIPC Toll Free: 561-391-5555 www.dawsonjames.com 1 North Federal Highway - Suite 500 Boca Raton, FL 33432 Biofrontera (Nasdaq/BFRA) BUY

More information

INSTITUTIONAL RESEARCH Biotechnology COMPANY UPDATE Member FINRA/SIPC

INSTITUTIONAL RESEARCH Biotechnology COMPANY UPDATE Member FINRA/SIPC INSTITUTIONAL RESEARCH Biotechnology COMPANY UPDATE Member FINRA/SIPC Toll Free: 561-391-5555 www.dawsonjames.com 1 North Federal Highway - Suite 500 Boca Raton, FL 33432 OncoSec Medical (Nasdaq/ONCS)

More information

INSTITUTIONAL RESEARCH Specialty Pharma COMPANY UPDATE Member FINRA/SIPC

INSTITUTIONAL RESEARCH Specialty Pharma COMPANY UPDATE Member FINRA/SIPC INSTITUTIONAL RESEARCH Specialty Pharma COMPANY UPDATE Member FINRA/SIPC Toll Free: 561-391-5555 www.dawsonjames.com 1 North Federal Highway - Suite 500 Boca Raton, FL 33432 Champions Oncology (Nasdaq/CSBR)

More information

INSTITUTIONAL RESEARCH Biotechnology COMPANY UPDATE Member FINRA/SIPC

INSTITUTIONAL RESEARCH Biotechnology COMPANY UPDATE Member FINRA/SIPC INSTITUTIONAL RESEARCH Biotechnology COMPANY UPDATE Member FINRA/SIPC Toll Free: 561-391-5555 www.dawsonjames.com 1 North Federal Highway - Suite 500 Boca Raton, FL 33432 Altimmune (Nasdaq/ALT) BUY Investment

More information

INSTITUTIONAL RESEARCH Specialty Pharma COMPANY UPDATE Member FINRA/SIPC

INSTITUTIONAL RESEARCH Specialty Pharma COMPANY UPDATE Member FINRA/SIPC INSTITUTIONAL RESEARCH Specialty Pharma COMPANY UPDATE Member FINRA/SIPC Toll Free: 561-391-5555 www.dawsonjames.com 1 North Federal Highway - Suite 500 Boca Raton, FL 33432 Sonoma Pharmaceuticals (Nasdaq/SNOA)

More information

EQUITY RESEARCH Telecom, Media, Tech COMPANY UPDATE

EQUITY RESEARCH Telecom, Media, Tech COMPANY UPDATE Member FINRA/SIPC Toll Free: 561-391-5555 www.dawsonjames.com EQUITY RESEARCH Telecom, Media, Tech COMPANY UPDATE Cinedigm Corp. (NASDAQ/CIDM) BUY Cinedigm is a streaming media company with channels focusing

More information

INSTITUTIONAL RESEARCH Specialty Pharma COMPANY UPDATE Member FINRA/SIPC

INSTITUTIONAL RESEARCH Specialty Pharma COMPANY UPDATE Member FINRA/SIPC INSTITUTIONAL RESEARCH Specialty Pharma COMPANY UPDATE Member FINRA/SIPC Toll Free: 561-391-5555 www.dawsonjames.com 1 North Federal Highway - Suite 500 Boca Raton, FL 33432 Pulmatrix (Nasdaq/PULM) BUY

More information

EQUITY RESEARCH Telecom, Media, Tech COMPANY UPDATE

EQUITY RESEARCH Telecom, Media, Tech COMPANY UPDATE 1 22 29 Feb 12 20 2 12 19 2 2 Mar Apr LIVEXLIVE M EDIA OR D (.9130,.9000,.0000,.2000, -0.01000) May Relative Strength Index ( 0.003) 1 21 29 Jun 11 1 2 2 Jul Aug 13 20 2 2000 100 1000 x10 0 12 11 11 10

More information

Darden Restaurants, Inc.

Darden Restaurants, Inc. Darden Restaurants, Inc. DRI: Reports Solid Performance; Expectations Were Pretty High Despite Evidence Segment Is Slowing Our View: We reiterate our OW rating following shares coming under pressure because

More information

EQUITY RESEARCH Biotechnology COMPANY UPDATE

EQUITY RESEARCH Biotechnology COMPANY UPDATE Member FINRA/SIPC Toll Free: 561-391-5555 www.dawsonjames.com EQUITY RESEARCH Biotechnology COMPANY UPDATE IMV, Inc. (Nasdaq/IMV) BUY Price Target $11.50 IMV is an immuno-oncology (IO) company with multiple

More information

Socket Mobile, Inc. (SCKT) NR Price Target: $6 Price: $4.04 Risk Rating: M. Sidoti & Company, LLC

Socket Mobile, Inc. (SCKT) NR Price Target: $6 Price: $4.04 Risk Rating: M. Sidoti & Company, LLC October 27, 2017 Company Sponsored Research Morning Meeting Note Earnings Release Socket Mobile, Inc. (SCKT) Equity Research Maintain $6 Price Target; Robust Demand From Application Developer, Despite

More information

INSTITUTIONAL RESEARCH Technology COMPANY UPDATE Member FINRA/SIPC

INSTITUTIONAL RESEARCH Technology COMPANY UPDATE Member FINRA/SIPC INSTITUTIONAL RESEARCH Technology COMPANY UPDATE Member FINRA/SIPC Toll Free: 561-391-5555 www.dawsonjames.com 1 North Federal Highway - Suite 500 Boca Raton, FL 33432 Sigma Labs (Nasdaq/SGLB) BUY New

More information

OTC Markets Group Inc. (OTCM) NR Price Target: $30 Price: $29.80 Risk Rating: H. Sidoti & Company, LLC

OTC Markets Group Inc. (OTCM) NR Price Target: $30 Price: $29.80 Risk Rating: H. Sidoti & Company, LLC September 29, 2017 Company Sponsored Research Morning Meeting Note Raise Price Target; Raise Earnings Estimates OTC Markets Group Inc. (OTCM) Equity Research Raise Target To $30 (From $27) As We Introduce

More information

EQUITY RESEARCH Biotechnology COMPANY UPDATE

EQUITY RESEARCH Biotechnology COMPANY UPDATE Member FINRA/SIPC Toll Free: 561-391-5555 www.dawsonjames.com EQUITY RESEARCH Biotechnology COMPANY UPDATE IMV, Inc. (Nasdaq/IMV) BUY Price Target US $15.00 IMV is an immuno-oncology (IO) company with

More information

AAON, Inc. (AAON) NEUTRAL Price Target: $34 Price: $ Sidoti & Company, LLC

AAON, Inc. (AAON) NEUTRAL Price Target: $34 Price: $ Sidoti & Company, LLC December 16, 2016 Morning Meeting Note Raise Price Target AAON, Inc. (AAON) Equity Research Raise Target To $34 (From $28) On Anticipation Of A Lower Tax Rate; Continue To Forecast Strong Growth In 2017-2018;

More information

AAON, Inc. (AAON) NEUTRAL Price Target: $35 Price: $ Sidoti & Company, LLC

AAON, Inc. (AAON) NEUTRAL Price Target: $35 Price: $ Sidoti & Company, LLC September 15, 2017 Morning Meeting Note Company Update AAON, Inc. (AAON) Equity Research We Maintain Our Outlook For Robust Growth For AAON, Following A Peer s Positive Commentary Earlier This Week; Maintain

More information

Release Date Conference Call Time (Eastern) Contact Co. Guidance Consensus May 9 May 10 8:30am TBA NA $0.29

Release Date Conference Call Time (Eastern) Contact Co. Guidance Consensus May 9 May 10 8:30am TBA NA $0.29 April 19, 2018 Company Sponsored Research Morning Meeting Note Earnings Preview OTC Markets Group Inc. (OTCM) Equity Research Forecast 10% EPS Growth In 1Q:18, Aided By Lower Taxes; View OTCM As Well Positioned

More information

AAON, Inc. (AAON) NEUTRAL Price Target: $33 Price: $ Sidoti & Company, LLC

AAON, Inc. (AAON) NEUTRAL Price Target: $33 Price: $ Sidoti & Company, LLC December 13, 2018 Morning Meeting Note Company Update AAON, Inc. (AAON) Equity Research In Our View, AAON s Outlook For 2019 Is Positive Based On Backlog, Order Trend And Price/Cost; However, We Are Cautious

More information

Sidoti & Company, LLC Member FINRA & SIPC Required disclosures appear in the Appendix.

Sidoti & Company, LLC Member FINRA & SIPC Required disclosures appear in the Appendix. Member FINRA & SIPC Required disclosures appear in the Appendix. 122 East 42 nd Street New York, NY 10168 (212) 297-0001 (212) 297-9166 www.sidoti.com AAON, Inc. (AAON-$26.20) Morning Meeting Note NEUTRAL

More information

Lower Price Target To $4 (From $6); Near-Term Trends Are Less Favorable, But We Think Investment In Products Should Yield Benefits Over Time

Lower Price Target To $4 (From $6); Near-Term Trends Are Less Favorable, But We Think Investment In Products Should Yield Benefits Over Time April 27, 2018 Company Sponsored Research Morning Meeting Note Lower Price Target; Lower Earnings Estimates Socket Mobile, Inc. (SCKT) Equity Research Lower Price Target To $4 (From $6); Near-Term Trends

More information

AAON, Inc. (AAON) NEUTRAL Price Target: $33 Price: $ Sidoti & Company, LLC

AAON, Inc. (AAON) NEUTRAL Price Target: $33 Price: $ Sidoti & Company, LLC November 1, 2018 Intraday Note Raise Earnings Estimates; Earnings Release AAON, Inc. (AAON) Equity Research Increase 2019 EPS Estimate After This Morning s Solid 3Q:18 Report; 3Q:18 EPS Of $0.27 Beat Our

More information

AAON, Inc. (AAON) NEUTRAL Price Target: $33 Price: $ Sidoti & Company, LLC

AAON, Inc. (AAON) NEUTRAL Price Target: $33 Price: $ Sidoti & Company, LLC February 28, 2019 Intraday Note Lower Earnings Estimates; Earnings Release AAON, Inc. (AAON) Equity Research 4Q:18 Revenue Beats, But EPS Misses On Soft Gross Margin; Although Backlog Supports Growth,

More information

Sidoti & Company, LLC Member FINRA & SIPC Required disclosures appear in the Appendix.

Sidoti & Company, LLC Member FINRA & SIPC Required disclosures appear in the Appendix. Member FINRA & SIPC Required disclosures appear in the Appendix. 122 East 42 nd Street New York, NY 10168 (212) 297-0001 (212) 297-9166 www.sidoti.com AAON, Inc. (AAON-$26.55) Morning Meeting Note NEUTRAL

More information

Small-Cap Research. Auxilio Inc. (AUXO-OTCQB) AUXO: Slow Start to the Year Creates Buying Opportunity OUTPERFORM OUTLOOK SUMMARY DATA ZACKS ESTIMATES

Small-Cap Research. Auxilio Inc. (AUXO-OTCQB) AUXO: Slow Start to the Year Creates Buying Opportunity OUTPERFORM OUTLOOK SUMMARY DATA ZACKS ESTIMATES Small-Cap Research May 15, 2014 Lisa Thompson 312-265-9154 lthompson@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Auxilio Inc. (AUXO-OTCQB) AUXO: Slow Start to the Year Creates Buying

More information

PARKERVISION, INC. Rating: STRONG BUY Target: $27. NASDAQ: PRKR - $15.75 Semiconductors Integrated Circuits

PARKERVISION, INC. Rating: STRONG BUY Target: $27. NASDAQ: PRKR - $15.75 Semiconductors Integrated Circuits EGE INSTITUTIONAL RESEARCH REPORT RESEARCH UPDATE DECEMBER 24, 2007 PARKERVISION, INC. NASDAQ: PRKR - $15.75 Semiconductors Integrated Circuits PRKR Signs First Mobile Handset Deal; Upgrading To STRONG

More information

PARKERVISION, INC. Rating: BUY Target: $27. NASDAQ: PRKR - $12.66 Semiconductors Integrated Circuits

PARKERVISION, INC. Rating: BUY Target: $27. NASDAQ: PRKR - $12.66 Semiconductors Integrated Circuits EGE INSTITUTIONAL RESEARCH REPORT RESEARCH UPDATE MAY 3, 2007 PARKERVISION, INC. NASDAQ: PRKR - $12.66 Semiconductors Integrated Circuits PRKR Announced A $25 Million Licensing Agreement With ITT Corp

More information

Activision Blizzard, Inc. ATVI NASDAQ Underperform-2

Activision Blizzard, Inc. ATVI NASDAQ Underperform-2 COMPANY UPDATE / ESTIMATE CHANGE Key Metrics ATVI - NASDAQ (as of 8/4/17) $62.01 Price Target N/A 52-Week Range $35.12 - $64.06 Shares Outstanding (mil) (basic) 754 Market Cap. ($mil) $46,756 3-Mo. Average

More information

Sidoti & Company, LLC Member FINRA & SIPC Required disclosures appear in the Appendix.

Sidoti & Company, LLC Member FINRA & SIPC Required disclosures appear in the Appendix. Member FINRA & SIPC Required disclosures appear in the Appendix. 122 East 42 nd Street New York, NY 10168 (212) 297-0001 (212) 297-9166 www.sidoti.com AAON, Inc. (AAON-$27.84) Morning Meeting Note NEUTRAL

More information

Akamai Technologies, Inc. Rating: Buy

Akamai Technologies, Inc. Rating: Buy COMMUNICATIONS TECHNOLOGY Erik Zamkoff 212-218-3850 ezamkoff@morganjoseph.com Company Update / Price Target Change December 21, 2005 Key Metrics AKAM - NASDAQ $19.66 Pricing Date 12/20/2005 Price Target

More information

Small-Cap Research. Net Element Inc. (NETE-NASDAQ) OUTLOOK. NETE: Russian Restructuring Should Reduces Losses SUMMARY DATA ZACKS ESTIMATES

Small-Cap Research. Net Element Inc. (NETE-NASDAQ) OUTLOOK. NETE: Russian Restructuring Should Reduces Losses SUMMARY DATA ZACKS ESTIMATES Small-Cap Research August 17, 2017 Lisa Thompson 312-265-9154 lthompson@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Net Element Inc. NETE: Russian Restructuring Should Reduces Losses

More information

Synthetic Biologics (SYN) Rating: Buy

Synthetic Biologics (SYN) Rating: Buy Earnings Update Healthcare August 15, 2013 h (SYN) Rating: Buy Andrew S. Fein 212-356-0546 afein@hcwco.com Continue to View Trimesta Deal in Multiple Sclerosis as NT Value Driver: Reiterate BUY and $4

More information

CalAmp Corp. CAMP - $ NASDAQ Buy

CalAmp Corp. CAMP - $ NASDAQ Buy Scott W. Searle, CFA, (646) 616-2782 ssearle@roth.com Sales (800) 933-6830, Trading (800) 933-6820 COMPANY NOTE EQUITY RESEARCH June 28, 2018 Technology: Communications, Wireless & IoT CalAmp Corp. CAMP

More information

Dollarama Inc. Q4 F2017 Results. A straight-forward beat and other notable business updates HIGHLIGHTS. The NBF Daily Bulletin.

Dollarama Inc. Q4 F2017 Results. A straight-forward beat and other notable business updates HIGHLIGHTS. The NBF Daily Bulletin. DOL (T) $110.88 Stock Rating: Outperform (Unchanged) Target: $122.00 (Was $113.00) Risk Rating: Below Average (Unchanged) Est. Total Return: 10.4% Stock Data: 52-week High-Low (Canada) Bloomberg $104.94

More information

AutoNation, Inc. AN: Company-Specific Headwinds Continue to Weigh on Results, but Cost Controls are Improving

AutoNation, Inc. AN: Company-Specific Headwinds Continue to Weigh on Results, but Cost Controls are Improving Consumer: Automotive Retail AutoNation, Inc. AN: Company-Specific Headwinds Continue to Weigh on Results, but Cost Controls are Improving Maintaining SW: 1) auto retail industry growth outlook remains

More information

Electronic Arts Inc. EA NASDAQ Neutral-2 Fiscal 3Q Results Don t Tell the Story of Bright Future, Long-term Growth Prospects

Electronic Arts Inc. EA NASDAQ Neutral-2 Fiscal 3Q Results Don t Tell the Story of Bright Future, Long-term Growth Prospects COMPANY UPDATE / ESTIMATE CHANGE Key Metrics EA - NASDAQ (as of 1/30/18) $118.70 Current intra-day price (1/31/18) $127.81 Two Year Price Target N/A 52-Week Range $80.40 - $122.79 Shares Outstanding (mil)

More information

We Raise Our Price Target To $4 (From $3); Think Strong Outlook For Revenue And EBITDA Growth Warrants Higher Valuation

We Raise Our Price Target To $4 (From $3); Think Strong Outlook For Revenue And EBITDA Growth Warrants Higher Valuation July 13, 2018 Company Sponsored Research Morning Meeting Note Raise Price Target Sify Technologies Limited Sponsored ADR (SIFY) Equity Research We Raise Our Price Target To $4 (From $3); Think Strong Outlook

More information

Analyst's Notes. Argus Recommendations

Analyst's Notes. Argus Recommendations Report created Jan 24, 2018 Page 1 OF 5 General Electric is one of the largest publicly traded companies in the world and is classified as a diversified industrials business. The stock is a component of

More information

Sidoti & Company, LLC Member FINRA & SIPC Required disclosures appear in the Appendix.

Sidoti & Company, LLC Member FINRA & SIPC Required disclosures appear in the Appendix. Member FINRA & SIPC Required disclosures appear in the Appendix. 122 East 42 nd Street New York, NY 10168 (212) 297-0001 (212) 297-9166 www.sidoti.com AAON, Inc. (AAON-$23.39) Morning Meeting Note NEUTRAL

More information

Alvarion Ltd. Rating: Buy

Alvarion Ltd. Rating: Buy TECHNOLOGY Kevin Dede, CFA 212-218-3714 kdede@morganjoseph.com Company Update June 11, 2008 Key Metrics ALVR - NASDAQ $7.95 Pricing Date 06/11/2008 Price Target $11.00 52-Week Range $15.21-$5.20 Shares

More information

Takeaways from Bullish Battery Analyst Day

Takeaways from Bullish Battery Analyst Day AUTO & TRUCK MANUFACTURING Sector Weighting Market Weight JOHNSON CONTROLS INC. (JCI $39.52 Outperform) Takeaways from Bullish Battery Analyst Day Upbeat, In-Depth Power Solutions (PS) Analyst Day. Yesterday,

More information

O'Reilly Automotive, Inc. Quick Read: Weather Likely Weighed Upon Sales a Bit

O'Reilly Automotive, Inc. Quick Read: Weather Likely Weighed Upon Sales a Bit EQUITY RESEARCH QUARTERLY UPDATE July 27, 2016 Stock Rating: OUTPERFORM 12-18 mo. Price Target $300.00 ORLY - NASDAQ $277.51 3-5 Yr. EPS Gr. Rate 18% 52-Wk Range $284.66-$225.12 Shares Outstanding 99.4M

More information

AutoZone, Inc. EQUITY RESEARCH QUARTERLY UPDATE OUTPERFORM. Quick Read: Sales a Bit Soft, But Results Solid. September 22, 2016

AutoZone, Inc. EQUITY RESEARCH QUARTERLY UPDATE OUTPERFORM. Quick Read: Sales a Bit Soft, But Results Solid. September 22, 2016 EQUITY RESEARCH QUARTERLY UPDATE September 22, 2016 Stock Rating: OUTPERFORM 12-18 mo. Price Target $900.00 AZO - NYSE $751.45 3-5 Yr. EPS Gr. Rate 14% 52-Wk Range $819.54-$681.01 Shares Outstanding 30.8M

More information

Analyst's Notes. Argus Recommendations

Analyst's Notes. Argus Recommendations Report created Jan 12, 2018 Page 1 OF 5 JPMorgan Chase is one of world's largest diversified banking firms. The company operates a leading global corporate and investment bank and is the second-largest

More information

Analyst's Notes. Argus Recommendations

Analyst's Notes. Argus Recommendations Report created Jul 23, 2015 Page 1 OF 5 Boeing manufactures commercial jetliners and military aircraft as well as rotorcraft, electronic and defense systems, missiles, satellites, launch vehicles, and

More information

Analyst's Notes. Argus Recommendations

Analyst's Notes. Argus Recommendations Report created Jan 17, 2018 Page 1 OF 5 Citigroup is one of world's largest banks, with global consumer banking, corporate banking, and investment banking operations. Of the largest U.S. banks, Citigroup

More information

Electronic Arts Inc. EA NASDAQ Neutral-2 Good 2Q Results; Neutral Rating Based on Stock Valuation

Electronic Arts Inc. EA NASDAQ Neutral-2 Good 2Q Results; Neutral Rating Based on Stock Valuation COMPANY UPDATE / ESTIMATE CHANGE Key Metrics EA - NASDAQ (as of 10/31/17) $119.60 Two Year Price Target N/A 52-Week Range $73.74 - $122.79 Shares Outstanding (mil) 309 Market Cap. ($mil) $36,956 3-Mo.

More information

Kingsoft (3888 HK) Buy (maintained) Target price: HK$ Q16 results in line, renewed growth outlook; maintain Buy with target price of HK$20.

Kingsoft (3888 HK) Buy (maintained) Target price: HK$ Q16 results in line, renewed growth outlook; maintain Buy with target price of HK$20. Equity Research Information Technology Kingsoft (3888 HK) Buy (maintained) Target price: HK$2.77 2Q16 results in line, renewed growth outlook; maintain Buy with target price of HK$2.77 2Q16 results in

More information

Kingsoft (3888 HK) Buy (maintained) Target price: HK$20.77

Kingsoft (3888 HK) Buy (maintained) Target price: HK$20.77 Equity Research Information Technology May 24, 216 Kingsoft (3888 HK) Buy (maintained) Target price: HK$2.77 Full-year earnings forecast trimmed as 1Q16 results miss; maintain Buy but lower target price

More information

Small-Cap Research (SILC-NASDAQ) SILC: Growth Eludes Silicom for the Next Few Quarters- Downgrading to Hold OUTLOOK SUMMARY DATA ZACKS ESTIMATES

Small-Cap Research (SILC-NASDAQ) SILC: Growth Eludes Silicom for the Next Few Quarters- Downgrading to Hold OUTLOOK SUMMARY DATA ZACKS ESTIMATES Small-Cap Research July 23, 2014 Lisa Thompson 312-265-9154 lthompson@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Silicom Limited (SILC-NASDAQ) SILC: Growth Eludes Silicom for the

More information

Analyst's Notes. Argus Recommendations

Analyst's Notes. Argus Recommendations Report created Nov 22, 2017 Page 1 OF 5 Based in London, BP is one of the world's five super majors. BP's operations are fully integrated, consisting of upstream, transportation, trading, refining, petrochemicals,

More information

Conn's Inc. Rating: Buy

Conn's Inc. Rating: Buy HARDLINE/LEISURE Jeffrey Blaeser 212-218-3739 jblaeser@morganjoseph.com Company Update August 8, 2007 Key Metrics CONN - NASDAQ $22.35 Pricing Date 08/07/2007 Price Target $34.00 52-Week Range $32.19-$17.61

More information

Sidoti & Company, LLC Member FINRA & SIPC Required disclosures appear in the Appendix.

Sidoti & Company, LLC Member FINRA & SIPC Required disclosures appear in the Appendix. Member FINRA & SIPC Required disclosures appear in the Appendix. 122 East 42 nd Street New York, NY 10168 (212) 297-0001 (212) 297-9166 www.sidoti.com AAON, Inc. (AAON-$20.47) Intraday Meeting Note NEUTRAL

More information

The Medicines Company Model Update; Busy Catalyst Calendar Ahead

The Medicines Company Model Update; Busy Catalyst Calendar Ahead EQUITY RESEARCH QUARTERLY UPDATE March 23, 2016 Stock Rating: PERFORM 12-18 mo. Price Target NA MDCO - NASDAQ $31.48 3-5 Yr. EPS Gr. Rate NA 52-Wk Range $43.79-$25.27 Shares Outstanding 68.9M Float 67.1M

More information

CENTENE CORP. Read-Thru From NY Governor s Budget to Fidelis Deal HEALTHCARE SERVICES. (CNC $ Peer Perform)

CENTENE CORP. Read-Thru From NY Governor s Budget to Fidelis Deal HEALTHCARE SERVICES. (CNC $ Peer Perform) HEALTHCARE SERVICES Managed Care Market Overweight CENTENE CORP (CNC $110.80 Peer Perform) Read-Thru From NY Governor s Budget to Fidelis Deal NY Governor s Budget Could Impact Fidelis Deal On 1/16/18

More information

Analyst's Notes. Argus Recommendations

Analyst's Notes. Argus Recommendations Report created Dec 29, 2011 Page 1 OF 5 United Technologies is an aerospace-industrial conglomerate whose portfolio includes Climate Control & Security (which now combines UTC Fire Security with Carrier),

More information

Dollarama Inc. Q2 F2017 Preview. (1) Growth expected to continue (2) A deeper look at valuation HIGHLIGHTS. The NBF Daily Bulletin.

Dollarama Inc. Q2 F2017 Preview. (1) Growth expected to continue (2) A deeper look at valuation HIGHLIGHTS. The NBF Daily Bulletin. DOL (T) $97.04 Stock Rating: Outperform (Unchanged) Target: $105.00 (Was $104.00) Risk Rating: Average (Unchanged) Est. Total Return: 8.6% Stock Data: 52-week High-Low (Canada) Bloomberg $98.94 - $66.32

More information

Small-Cap Research. SMTP Inc. (SMTP-NASDAQ) SMTP: Announces Secondary to Raise Cash and Accelerate Marketing, Cutting Earnings Forecast OUTLOOK

Small-Cap Research. SMTP Inc. (SMTP-NASDAQ) SMTP: Announces Secondary to Raise Cash and Accelerate Marketing, Cutting Earnings Forecast OUTLOOK Small-Cap Research August 5, 2015 Lisa Thompson 312-265-9154 lthompson@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 SMTP Inc. (SMTP-NASDAQ) SMTP: Announces Secondary to Raise Cash and

More information

Company Report. TCL Comm (2618 HK) Strong FY15E ahead backed by solid product roadmap in smartphone/wearables/apps/cloud; Reiterate BUY BUY

Company Report. TCL Comm (2618 HK) Strong FY15E ahead backed by solid product roadmap in smartphone/wearables/apps/cloud; Reiterate BUY BUY Company Report China Merchants Securities (HK) Co.Ltd. Hong Kong Equity Research TCL Comm (2618 HK) Strong FY15E ahead backed by solid product roadmap in smartphone/wearables/apps/cloud; Reiterate BUY

More information

Sterling Construction Company, Inc. Rating: Hold

Sterling Construction Company, Inc. Rating: Hold ENGINEERING & CONSTRUCTION Richard S. Paget, CFA 212-218-3894 rpaget@morganjoseph.com Christopher Bamman 212-218-3989 cbamman@morganjoseph.com Company Update / Estimates Change May 11, 2006 Key Metrics

More information

Zacks Small-Cap Research

Zacks Small-Cap Research Zacks Small-Cap Research Sponsored Impartial - Comprehensive March 19, 2018 David Bautz, PhD 312-265-9471 dbautz@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Aralez Pharmaceuticals

More information

Alphabet Inc. GOOGL - NASDAQ Neutral -1

Alphabet Inc. GOOGL - NASDAQ Neutral -1 COMPANY UPDATE / TARGET CHANGE ESTIMATE CHANGE Key Metrics GOOGL - NASDAQ - as of 5/1/17 $932.82 Price Target $1,000.00 52-Week Range $672.66 - $935.82 Diluted Shares Outstanding (mil) 702.0 Market Cap.

More information

Allscripts Healthcare Solutions, Inc.

Allscripts Healthcare Solutions, Inc. HEALTHCARE: Healthcare Technology Company Update / Estimates Change Allscripts Healthcare Solutions, Inc. MDRX: Continuing the String of Bookings We reiterate our SW rating on Allscripts (MDRX) due to

More information

Equity Research. Bank of the Ozarks, Inc. (OZRK-NSDQ) OUTLOOK SUMMARY DATA ZACKS ESTIMATES. Hold Prior Recommendation. Current Recommendation

Equity Research. Bank of the Ozarks, Inc. (OZRK-NSDQ) OUTLOOK SUMMARY DATA ZACKS ESTIMATES. Hold Prior Recommendation. Current Recommendation Equity Research July 14, 2006 Scott A. Jaggers, CFA www.zacks.com 155 North Wacker Drive Chicago, IL 60606 Bank of the Ozarks, Inc. (OZRK-NSDQ) Current Recommendation Hold Prior Recommendation Sell Date

More information

[Please refer to Appendix. Wells Fargo & Company (WFC) Q2 Initial Thoughts: Revenue Trends Modestly Below Expectations RESEARCH UPDATE

[Please refer to Appendix. Wells Fargo & Company (WFC) Q2 Initial Thoughts: Revenue Trends Modestly Below Expectations RESEARCH UPDATE July 15, 2016 Baird Equity Research US Banks Wells Fargo & Company (WFC) Q2 Initial Thoughts: Revenue Trends Modestly Below Expectations WFC reported Q216 EPS of $1.01 (Baird $1.02, consensus $1.01). Non-core

More information

Industry Overview February 16, 2010

Industry Overview February 16, 2010 Industry Overview February 16, 2010 Enterprise Software Brendan Barnicle 503.727.0624 bbarnicle@pacific-crest.com Matthew Coss 503.727.0622 mcoss@pacific-crest.com With Expectations Reset, Time to Add

More information

Research Report Update Investors should consider this report as only a single factor in making their investment decision.

Research Report Update Investors should consider this report as only a single factor in making their investment decision. The Standard of Excellence in the Microcap Market Member: NASD, SIPC Research Report Update Investors should consider this report as only a single factor in making their investment decision. AeroCentury

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Boston EQUITY RESEARCH Company Report November 8, 2018 Viking Therapeutics (VKTX - $13.74) 3Q18: Conference Call Uneventful with Investor Focus on the Design

More information

Oramed Pharmaceuticals Inc. (ORMP $7.21*)

Oramed Pharmaceuticals Inc. (ORMP $7.21*) Oramed Pharmaceuticals Inc. (ORMP $7.21*) Healthcare: Specialty Pharmaceuticals Buy; $20.00 PT; $104.2M Market Cap Company Update Tuesday, April 17, 2018 Revenue/EPS for 2Q18 in Line/Beat Estimates; Time

More information

Analyst's Notes. Argus Recommendations

Analyst's Notes. Argus Recommendations Report created Feb 2, 2012 Page 1 OF 5 Founded in 1940 and based in Charlotte, North Carolina, Nucor Corp. is a manufacturer of steel and steel products and North America's largest steel recycler. The

More information

Table 1. Sum-of-the-parts valuation. EPS Growth

Table 1. Sum-of-the-parts valuation. EPS Growth (001120) Solid 4Q, excluding one-offs (LGI) yesterday reported that its consolidated sales rose 3.8% q-q to KRW3.8t in 4Q, but that its operating profit plunged 98% q-q to KRW600m with a net loss of KRW237.2b,

More information

Comcast EQUITY RESEARCH QUARTERLY UPDATE OUTPERFORM. Comcast 2Q16 Follow-Up: Raising Price Target to $74, 8x 2017E EBITDA.

Comcast EQUITY RESEARCH QUARTERLY UPDATE OUTPERFORM. Comcast 2Q16 Follow-Up: Raising Price Target to $74, 8x 2017E EBITDA. EQUITY RESEARCH QUARTERLY UPDATE July 29, 2016 Stock Rating: OUTPERFORM 12-18 mo. Price Target $74.00 CMCSA - NASDAQ $67.86 3-5 Yr. EPS Gr. Rate 17% 52-Wk Range $68.36-$50.01 Shares Outstanding 2,446.0M

More information

Asure Software, Inc. (NasdaqCM: ASUR)

Asure Software, Inc. (NasdaqCM: ASUR) Asure Software, Inc. (NasdaqCM: ASUR) July 13, 2012 Rating: Strong Buy Target Price: $19.15 Recent Price: $7.45 Analyst Specialist Thomas Pfister Jon Cunningham 800-733-2447 800-733-2447 Ext. 107 Thomas@redchip.com

More information

Stryker Corp. Post-4Q15 Thoughts

Stryker Corp. Post-4Q15 Thoughts EQUITY RESEARCH QUARTERLY UPDATE January 27, 2016 Stock Rating: PERFORM 12-18 mo. Price Target $104.00 SYK - NYSE $96.02 3-5 Yr. EPS Gr. Rate 9% 52-Wk Range $105.34-$86.68 Shares Outstanding 378.4M Float

More information

CMS ENERGY CORPORATION Earnings Per Share By Year GAAP Reconciliation (Unaudited)

CMS ENERGY CORPORATION Earnings Per Share By Year GAAP Reconciliation (Unaudited) GAAP Reconciliation CMS ENERGY CORPORATION Earnings Per Share By Year GAAP Reconciliation (Unaudited) 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 Reported earnings (loss) per

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Stamford Ft. Lauderdale EQUITY RESEARCH Company Report Cytori Therapeutics (CYTX - $ 2.32) BARDA Decision is a Major Positive Development Yesterday, CYTX

More information

MEXICAN AIRPORTS EARNINGS PREVIEW

MEXICAN AIRPORTS EARNINGS PREVIEW Latin American Equity Research Mexico City, April 20, 2009 Sector Preview Mexico Aerospace & Transportation MEXICAN AIRPORTS EARNINGS PREVIEW A Tough 1Q09, Driven by Weak Passenger Figures Luis Miranda,

More information

Bermaz Auto Strong comeback

Bermaz Auto Strong comeback 13 March 2018 3QFY18 Result Review Bermaz Auto Strong comeback INVESTMENT THESIS 3Q18 results in-line Earnings gapped up 82%qoq and 61%yoy MMSB volumes/earnings hit record high Re-affirm BUY at unchanged

More information

Equity Research. CenterPoint Energy, Inc. CNP: Utilities Save The Day In 15A & 16E Silent On Strategic Review Until 2H. Outperform.

Equity Research. CenterPoint Energy, Inc. CNP: Utilities Save The Day In 15A & 16E Silent On Strategic Review Until 2H. Outperform. February 26, 2016 Equity Research CenterPoint Energy, Inc. CNP: Utilities Save The Day In 15A & 16E Silent On Strategic Review Until 2H Summary. We continue to be encouraged that CNP is able to deliver

More information

Please see pages 8 and 9 of this publication for important certification and disclosure information.

Please see pages 8 and 9 of this publication for important certification and disclosure information. Industry: Financial Services GICS Sector/ Sub code: Financials Sector / Banks (GIC Code: 40 / Sub code: 4010) Company Summary: Lending Club ( LC, or the Company) is the world s largest online marketplace

More information

D-Link India (DLILIM) 105

D-Link India (DLILIM) 105 Company Update Rating matrix Rating : Buy Target : 140 Target Period : 18-24 months Potential Upside : 34% What s Changed? Target Changed from 150 to 140 EPS FY18E Changed from 11.4 to 9.5 EPS FY19E Introduced

More information

[Please refer to Appendix. Sherwin-Williams Co. (SHW) High-Quality Beat Positive for Shares RESEARCH UPDATE

[Please refer to Appendix. Sherwin-Williams Co. (SHW) High-Quality Beat Positive for Shares RESEARCH UPDATE April 21, 2016 Baird Equity Research Packaging & Coatings Sherwin-Williams Co. (SHW) High-Quality Beat Positive for Shares Strong start to 2016 led by core sales. We believe that the shares of Sherwin-Williams

More information

Kingsoft (3888 HK) Buy (maintained) Target price: HK$ Strong earnings recovery ahead amid continued revenue momentum; maintain Buy

Kingsoft (3888 HK) Buy (maintained) Target price: HK$ Strong earnings recovery ahead amid continued revenue momentum; maintain Buy Equity Research Information Technology Mar 29, 216 Kingsoft (3888 HK) Buy (maintained) Target price: HK$24.7 Strong earnings recovery ahead amid continued revenue momentum; maintain Buy FY1 results in

More information

Release Date Conference Call Time (Eastern) Contact Co. Guidance Consensus TBD TBD TBD TBD N/A $0.02

Release Date Conference Call Time (Eastern) Contact Co. Guidance Consensus TBD TBD TBD TBD N/A $0.02 October 9, 2018 Company Sponsored Research Morning Meeting Note Earnings Preview Sify Technologies Limited Sponsored ADR (SIFY) Equity Research Expect 2Q:F19 EPS Will Be Flat Year Over Year On 15% Higher

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Boston EQUITY RESEARCH Company Report May 24, 2017 Asterias Biotherapeutics (AST - $3.15) Seasoned Management Team with Successful Record Reunited Yesterday

More information

Navigant Consulting Inc.

Navigant Consulting Inc. February 17, 2015 Navigant Consulting Inc. Current Recommendation SUMMARY DATA NEUTRAL Prior Recommendation Outperform Date of Last Change 08/15/2013 Current Price (02/16/15) $14.99 Target Price $16.00

More information

LAIDLAW & COMPANY Est. 1842

LAIDLAW & COMPANY Est. 1842 LAIDLAW & COMPANY London New York San Francisco Stamford Ft. Lauderdale EQUITY RESEARCH Company Report Mast Therapeutics (MSTX - $ 0.56) Rivipansel (GMI-1070) in Resolving Vaso-occlusive Crisis (VOC) of

More information

Pharming Group NV (OTC: PHGUF) PHARM.AS AEX Buy

Pharming Group NV (OTC: PHGUF) PHARM.AS AEX Buy Scott R. Henry, CFA, (949) 720-7123 shenry@roth.com Sales (800) 933-6830, Trading (800) 933-6820 Healthcare: BioPharmaceuticals COMPANY NOTE EQUITY RESEARCH May 18, 2017 Pharming Group NV (OTC: PHGUF)

More information

Sector: Internet Infrastructure ANALYST: Charles Giaquinto (212)

Sector: Internet Infrastructure ANALYST: Charles Giaquinto (212) Research Report - August 17, 2006 Akamai Technologies, Inc. (AKAM) Rating: Sector: Internet Infrastructure ANALYST: Charles Giaquinto (212) 675-4100 cgiaquinto@henleyandcompany.com Speculative Buy Company

More information

Energy & Natural Resources: Oil & Gas E&P

Energy & Natural Resources: Oil & Gas E&P Southwestern Energy Company (SWN $37.61*) Energy & Natural Resources: Oil & Gas E&P Raise Price Target Houston, TX Outperform February 25, 2011 Price Target: $45.00 STOCK DATA 52 Week Range $45.30 $30.61

More information

The Ensign Group, Inc. (NASDAQ:ENSG)

The Ensign Group, Inc. (NASDAQ:ENSG) The Ensign Group, Inc. (NASDAQ:ENSG) ENSG - Thesis Remains Intact; Reiterate MO MARKET OUTPERFORM COMPANY UPDATE Post Acute Care - Facilities February 14, 2013 Kevin Campbell, CFA, Managing Director kcampbell@avondalepartnersllc.com

More information

LoopNet. $28 $26 $24 $22 $20 $18 $16 $14 $12 $10 Jun-06 Sep-06 Dec-06 Mar-07 Jun-07

LoopNet. $28 $26 $24 $22 $20 $18 $16 $14 $12 $10 Jun-06 Sep-06 Dec-06 Mar-07 Jun-07 July 31, 2007 Analyst Highlights Street Estimates Recommendation: BUY 2006A 2007E 2008E Current Price: $21.01 EPS $0.40 $0.48 $0.59 Target Price: $25.00 P/E 52.5 43.8 35.6 Forecast Stock Return: 19.0%

More information

scr.zacks.com 10 S. Riverside Plaza, Chicago, IL (STVI-OTC) OUTLOOK ZACKS ESTIMATES Earnings Per Share

scr.zacks.com 10 S. Riverside Plaza, Chicago, IL (STVI-OTC) OUTLOOK ZACKS ESTIMATES Earnings Per Share Small-Cap Research September 15, 2017 M. Marin 312-265-9211 mmarin@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Snap Interactive (STVI-OTC) STVI: LiveXLive Offer Represents More Than

More information

ALPHA SELECT LIST CAS Medical Systems, Inc.

ALPHA SELECT LIST CAS Medical Systems, Inc. A Matt G. Hewitt Senior Research Analyst 612-334-6314 matthew.hewitt@craig-hallum.com Lucas Baranowski Research Analyst 612-334-8224 lucas.baranowski@craig-hallum.com Charlie Eidson, CPA Research Analyst

More information

Family Zone Cyber Safety Limited (FZO) Company Update. Investment Summary. Investment Highlights. Investment Recommendation

Family Zone Cyber Safety Limited (FZO) Company Update. Investment Summary. Investment Highlights. Investment Recommendation BW EQUITIES RESEARCH 14 March 2017 Family Zone Cyber Safety Limited (FZO) Company Update BUY Rating: Target Price 1 : $0.46 Projected Return: 109% 1 12 month target Company Statistics Share Price (A$)

More information

Mahindra and Mahindra Maintain Outperformer. (Rs mn) Mar 14 Mar 15 YoY (%) Dec 14 QoQ (%) FY14 FY15P YoY (%) FY16E YoY (%) FY17E YoY (%)

Mahindra and Mahindra Maintain Outperformer. (Rs mn) Mar 14 Mar 15 YoY (%) Dec 14 QoQ (%) FY14 FY15P YoY (%) FY16E YoY (%) FY17E YoY (%) Batlivala & Karani RESULT UPDATE Mahindra and Mahindra Maintain Outperformer LARGE CAP Share Data Reuters code Bloomberg code MAHM.BO MM IN Market cap. (US$ mn) 12,243 6M avg. daily turnover (US$ mn) 21.0

More information

Small-Cap Research. SMTP Inc. (SMTP-NASDAQ) SMTP: Zacks Company Report EARNINGS UPDATE Acquisition Integration- Short Term Pain For Long Term Gain

Small-Cap Research. SMTP Inc. (SMTP-NASDAQ) SMTP: Zacks Company Report EARNINGS UPDATE Acquisition Integration- Short Term Pain For Long Term Gain Small-Cap Research November 14, 2014 Lisa Thompson 312-265-9154 lthompson@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 SMTP Inc. (SMTP-NASDAQ) SMTP: Zacks Company Report EARNINGS UPDATE

More information

HCC BUY. Infrastructure April 10, QIP step in the right direction EVENT UPDATE. India Research. Bloomberg: HCC IN Reuters: HCNS.

HCC BUY. Infrastructure April 10, QIP step in the right direction EVENT UPDATE. India Research. Bloomberg: HCC IN Reuters: HCNS. Jan-14 Mar-14 Apr-14 May-14 Jul-14 Aug-14 Sep-14 Nov-14 Dec-14 Jan-15 India Research Infrastructure April 10, 2015 EVENT UPDATE Bloomberg: IN Reuters: HCNS.BO BUY QIP step in the right direction has successfully

More information

SodaStream Follow-Up: 1Q Results Better Than Expected; Guidance Raised; Wal-Mart!!!

SodaStream Follow-Up: 1Q Results Better Than Expected; Guidance Raised; Wal-Mart!!! EQUITY RESEARCH COMPANY UPDATE May 9, 2012 Stock Rating: OUTPERFORM 12-18 mo. Price Target $55.00 SODA - NASDAQ $36.90 3-5 Yr. EPS Gr. Rate 30% 52-Wk Range $79.72-$27.60 Shares Outstanding 19.9M Float

More information